Sign In

Karsten Miermans

improving clinical cytometry with machine learning | hema.to co-founder

Karsten Miermans, CEO and Co-founder of hema.to

Karsten Miermans is the CEO and co-founder of hema.to, a Munich-based health tech startup bringing AI automation to the clinical analysis of blood data.123457 He has a background in biophysics, software development, data science and entrepreneurship.5

Miermans co-founded hema.to in 2021 with the mission to make clinical analysis of cytometry data completely objective and enable doctors to personalize treatment to their patient's unique immune system.1 The company has developed a breakthrough AI-powered diagnostic platform for leukemia and lymphoma that is already in routine use by leading hematology laboratories.3

Under Miermans' leadership, hema.to recently raised a €3.6 million seed funding round from investors including Elaia Partners, Heal Capital, and High-Tech Gründerfonds (HTGF).12 The funds will allow the company to grow its team of software engineers and immunologists, and scale its AI capabilities.2

Miermans is passionate about improving cytometry and blood diagnostics to advance precision immune medicine.4 He frequently speaks about hema.to's mission and technology at industry events.6

Highlights

Jul 12 · linkedin

📣 We are looking for a skilled product owner to get our AI software for blood testing to the next level, reach PMF and scale it globally in the next 1-2 years including FDA clearance. 🎯 We’re on a mission to enable precision immune medicine for millions of people. Reach out to my cofounder if this interests you!

Feb 16 · linkedin

🚀We’re looking for a motivated and competent frontend/UI developer to help make leukemia diagnosis faster and better with our AI diagnostic support product. You can write our CTO Felix, he’s excited to meet you! 🙂

Related Questions

What inspired Karsten Miermans to co-found hema.to?
How did Karsten Miermans' background influence his leadership at hema.to?
What are Karsten Miermans' main goals for hema.to in the next few years?
How has Karsten Miermans' experience in AI impacted hema.to's technology?
What challenges has Karsten Miermans faced as CEO of hema.to?
Karsten Miermans
Karsten Miermans, photo 1
Karsten Miermans, photo 2
Add to my network

Location

Munich, Bavaria, Germany